2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
KT, ¿ÃÇØ ¸¶Áö¸· ¡®Ã»ÃáѨUP ÅäÅ©Äܼ­Æ®¡¯ (2016-11-10)
apoc-»ï¼º¹°»ê, ±¹³» ÃÖÃÊ XR ÄÜÅÙÃ÷ üÇè ÆË¾÷ ¼±º¸Àδ٠(2024-09-30)
À¯ºí·°½º, ½ºÇªÇÎ ¹× Àç¹Ö ¹æÁö ±â´É °­È­ (2024-09-06)
¹ÂÁö¼Ç À±»ó, âÀÛ ±¹¾Ç ±×·ì ¡®Ã¢ÀÛ ¾ÆÆ¼½ºÆ® ¿À´Ã¡¯À» ¸¸³ª´Ù (2024-12-21)
Andersen Consulting Adds Stratence Partners (2025-06-10)
GCT Semiconductor Holding, Inc. Provides Business Update and... (2025-04-06)
KG ¸ðºô¸®Æ¼, ¼Ûź°ü±¤Æ¯±¸ ÇѸ¶À½´ëÃàÁ¦ ÄÚ¶õµµ ÈÄ¿ø (2024-10-01)
Rimini Street Announced Rimini Protect¢â Advanced Hypervisor... (2025-01-31)
LG Recognized for Excellence in Design at iF Design Award 20... (2025-03-29)
¿¡½ºÆ¼Á¨¹ÙÀÌ¿À ¼Ûµµ¹ÙÀÌ¿À°øÀå, ¹Ì±¹ FDA ½ÂÀΠȹµæ (2024-11-03)
À§Àå °Ç°­ °³¼±¿¡ È¿°úÀûÀÌ°í ¾ÈÀüÇÑ ½ÄÀÌ º¸ÃæÁ¦·Î ÀÔÁõ (2024-10-26)
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitr... (2025-03-05)
'µ¶¹ÚÅõ¾î¡¯ È«ÀαÔ, ÀϺ»¿¡¼­ À¯¼¼À±°ú µÎ ¹øÂ° ÀÔ¸ÂÃã ¼º»ç? (2024-12-14)
ÇØ°¡ Áö³ª¸é ³» Â÷ °¡°Ýµµ º¯ÇÑ´Ù (2024-12-06)
ÄÚÄ¡ ¹é Çϳª·Î ³¡³»´Â Æ®·»µðÇÑ Ä·ÆÛ½º ÆÐ¼Ç (2024-09-08)
¡®ÇÁºñƼ¡¯ ÇÁ·£Â÷ÀÌÁî ÅëÇÕ Æ÷ÀÎÆ® ó¸® ±â¼ú ƯÇã µî·Ï (2024-11-12)
¾ÆÀ̺í¼ÒÇÁÆ®, À¯Åë ¹× ¹«¿ª¾÷ Ưȭ AI ERP ¡®ICE AI+¡¯ Ãâ½Ã (2024-10-03)
¾¾¿¡½ºÁ¶¼±Çªµå, ±¹³» °í±Þ ºê·£µå½Ò ¡®Á¶¼±Çâ¹Ì¡¯ Áï¼®¹ä Ãâ½Ã (2024-10-03)
û¼Ò³â °ÔÀÓ°ú¸ôÀÔ ÇØ°á¿¡ Àι®ÇÐ Ä¡À¯ ÇÁ·Î±×·¥ È¿°ú (2024-12-07)
»ï¼ºÀüÀÚ, °¶·°½Ã S24 ½Ã¸®Áî ¡®One UI 7¡¯ º£Å¸ ÇÁ·Î±×·¥ ¿î¿µ (2024-12-07)
Lazard and Arini Enter Cooperation and Sourcing Agreement fo... (2025-04-07)
ExaGrid Honored with Placement in the 2025 CRN¢ç Partner Pro... (2025-04-07)
¡®´ë¸¸ ÆÐ¹Ð¸®¡¯ äÁöÇý-Çϼº¿¬, ŸÀ̳­ ¸Ô¹æ Åõ¾î·Î ¡®Ä§»ù ÀÚ... (2024-10-28)
µü 3³â, °øºÎ¸¸ ÇÏ´Â ¹Ùº¸°¡ µÅ¶ó (2023-07-27)
¾Æµð´Ù½º, ¡®¾ÆµðÁ¦·Î ¾Æµð¿À½º ÇÁ·Î 4¡¯ ¼­¿ï¸¶¶óÅæ ¿¡µð¼Ç ¹ß... (2025-02-02)
       [ÀÌÀü][1]....[393][394][395][396][397][398][399][400][401]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..